<DOC>
	<DOCNO>NCT01816958</DOCNO>
	<brief_summary>application external neuromodulation along ketamine infusion .</brief_summary>
	<brief_title>Neuromodulation Facilitate Effect Ketamine</brief_title>
	<detailed_description>apply TMS concurrent ketamine infusion order increase likliehood &amp; strength therapeutic benefit</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>chronically ill , treatmentresistant active psychosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>thalamocortical dysrhythmia</keyword>
	<keyword>transcranial magnetic stimulation ( TMS )</keyword>
	<keyword>transcranial Electrical Stimulation ( tES )</keyword>
	<keyword>( N-methyl-D-aspartate ) NMDA-R antagonist</keyword>
	<keyword>ketamine infusion</keyword>
	<keyword>neuromodulation</keyword>
	<keyword>synergistic effect</keyword>
	<keyword>remission</keyword>
</DOC>